Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

NCT02273765 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

460

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-1 Infection
Tuberculosis

Interventions

DRUG: Tenofovir + lamivudine + raltegravir
DRUG: Tenofovir + lamivudine + efavirenz

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]